Najmeh Rezaeinezhad
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Najmeh Rezaeinezhad has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Marica Colella
Department of Theoretical and Applied Sciences (DiSTA), eCampus University, 22060 Novedrate, Italy
2 shared publications - Alessia Felicetti
Department of Medical and Surgical Sciences, Magna Graecia University, 88100 Catanzaro, Italy
1 shared publication - Alireza Ghardashi Afousi
Department of Exercise Physiology, Faculty of Sport Science and Health University of Tehran Tehran Iran
1 shared publication - Domenico Azzolino
Geriatric Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di Milano, Milan, Italy
1 shared publication - Elona Gaxhja
Department of Clinical Disciplines, University ‘Alexander Xhuvani’ of Elbasan, 3001 Elbasan, Albania
1 shared publication - Gabriel César Dias Lopes
Department of Neuroscience and Mental Health, School of Science of Health, Logos University International (UNILOGOS), Miami, FL 33137, USA
1 shared publication
Latest Publications
- Open Access
- 7 July 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1) , 27399
High-intensity interval training enhanced cardioprotective effects of neuregulin-1 against doxorubicin-induced cardiotoxicity
Doxorubicin (DOX) is an anthracycline chemotherapeutic agent widely used to treat a various cancer due to its potent therapeutic effects. However, its clinical application is limited by severe toxicity in multiple tissues particularly the heart, as well as liver, kidneys, and nervous system. Neuregulin-1 (NRG-1), an epidermal growth factor produced by cardiac endothelial cells, plays a protective role against these injuries by activating ErbB2/4 receptors and the PI3K/Akt signaling pathway. Evidence suggests that NRG-1 prevents myofibrillar damage and troponin degradation. In addition, exercise as a non-pharmacological intervention enhances these protective pathways by upregulation NRG-1 signaling and reducing cardiomyocytes apoptosis induced by DOX. The aim of this study was to investigate the effects of eight weeks of high-intensity interval training (HIIT) on NRG-1/ErbB signaling pathway in male Wistar rats induced by DOX-induced cardiotoxicity. Twenty-four male Wistar rats were randomly assigned into three groups (n = 8 per group): control healthy, DOX control, and DOX-HIIT. Cardiotoxicity was induced by six intraperitoneal injections of DOX (2 mg/kg per dose) administrated over a 12-day period, while the healthy control group received normal saline. The exercise protocol consisted of eight weeks of HIIT, performed three times per week. Each session included a 5-min warm-up, five 4-min high-intensity interval (85–90% of maximum oxygen consumption [VO2max]) interspersed with 2-min active recovery (50–60% of VO2max), and a 5-min cool-down. The end of the intervention, cardiac tissue and blood samples were collected for analysis. Protein expression was assessed using Western blotting. Statistical analysis was performed using one-way ANOVA followed by Tukey’s post hoc test. The results demonstrated that HIIT significantly improvements in left ventricular end-systolic diameter, stroke volume, ejection fraction, and fractional shortening compared to DOX-treated sedentary rats. These findings indicated that HIIT attenuates DOX-induced structural and functional cardiac impairment, potentially through modulation of the NRG-1/ErbB signaling pathway.
- 7 July 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1) , 27399
Open AccessHigh-intensity interval training enhanced cardioprotective effects of neuregulin-1 against doxorubicin-induced cardiotoxicity
Doxorubicin (DOX) is an anthracycline chemotherapeutic agent widely used to treat a various cancer due to its potent therapeutic effects. However, its clinical application is limited by severe toxicity in multiple tissues particularly the heart, as well as liver, kidneys, and nervous system. Neuregulin-1 (NRG-1), an epidermal growth factor produced by cardiac endothelial cells, plays a protective role against these injuries by activating ErbB2/4 receptors and the PI3K/Akt signaling pathway. Evidence suggests that NRG-1 prevents myofibrillar damage and troponin degradation. In addition, exercise as a non-pharmacological intervention enhances these protective pathways by upregulation NRG-1 signaling and reducing cardiomyocytes apoptosis induced by DOX. The aim of this study was to investigate the effects of eight weeks of high-intensity interval training (HIIT) on NRG-1/ErbB signaling pathway in male Wistar rats induced by DOX-induced cardiotoxicity. Twenty-four male Wistar rats were randomly assigned into three groups (n = 8 per group): control healthy, DOX control, and DOX-HIIT. Cardiotoxicity was induced by six intraperitoneal injections of DOX (2 mg/kg per dose) administrated over a 12-day period, while the healthy control group received normal saline. The exercise protocol consisted of eight weeks of HIIT, performed three times per week. Each session included a 5-min warm-up, five 4-min high-intensity interval (85–90% of maximum oxygen consumption [VO2max]) interspersed with 2-min active recovery (50–60% of VO2max), and a 5-min cool-down. The end of the intervention, cardiac tissue and blood samples were collected for analysis. Protein expression was assessed using Western blotting. Statistical analysis was performed using one-way ANOVA followed by Tukey’s post hoc test. The results demonstrated that HIIT significantly improvements in left ventricular end-systolic diameter, stroke volume, ejection fraction, and fractional shortening compared to DOX-treated sedentary rats. These findings indicated that HIIT attenuates DOX-induced structural and functional cardiac impairment, potentially through modulation of the NRG-1/ErbB signaling pathway.
- Open Access
- 1 December 2025
- Published by MDPI AG in Microorganisms
- Vol. 13 (12) , 2741
The Oral–Brain Axis in Alzheimer’s Disease: From Microbial Dysbiosis to Neurodegeneration
Alzheimer’s disease (AD), the most prevalent form of dementia, still lacks a clearly defined pathogenesis and effective disease-modifying therapies, prompting growing interest in peripheral drivers of neurodegeneration. Among these, chronic oral dysbiosis has emerged as a potential risk factor. Disruption of the oral ecosystem in periodontitis promotes systemic inflammation and the circulation of bacterial products capable of influencing brain homeostasis. By integrating molecular findings with epidemiological data linking periodontitis, tooth loss, and poor oral health to increased AD risk, this review examines how oral dysbiosis contributes to systemic inflammation as part of a broader network of interacting factors involved in AD pathophysiology. It describes how inflammatory, gut-microbial, genetic, and barrier-related processes intersect with oral dysbiosis and jointly contribute to the acceleration of AD progression. Building on this systemic perspective, the review highlights emerging oral biomarkers and oral–gut microbiota-targeted therapies as potential tools to address current gaps in early diagnosis and intervention. Overall, this work advances current understanding by integrating previously fragmented evidence and highlighting the key conceptual and methodological gaps that must be addressed to clarify causality and to guide the development of preventive and therapeutic approaches targeting oral health in the context of AD.
- 1 December 2025
- Published by MDPI AG in Microorganisms
- Vol. 13 (12) , 2741
Open AccessThe Oral–Brain Axis in Alzheimer’s Disease: From Microbial Dysbiosis to Neurodegeneration
Alzheimer’s disease (AD), the most prevalent form of dementia, still lacks a clearly defined pathogenesis and effective disease-modifying therapies, prompting growing interest in peripheral drivers of neurodegeneration. Among these, chronic oral dysbiosis has emerged as a potential risk factor. Disruption of the oral ecosystem in periodontitis promotes systemic inflammation and the circulation of bacterial products capable of influencing brain homeostasis. By integrating molecular findings with epidemiological data linking periodontitis, tooth loss, and poor oral health to increased AD risk, this review examines how oral dysbiosis contributes to systemic inflammation as part of a broader network of interacting factors involved in AD pathophysiology. It describes how inflammatory, gut-microbial, genetic, and barrier-related processes intersect with oral dysbiosis and jointly contribute to the acceleration of AD progression. Building on this systemic perspective, the review highlights emerging oral biomarkers and oral–gut microbiota-targeted therapies as potential tools to address current gaps in early diagnosis and intervention. Overall, this work advances current understanding by integrating previously fragmented evidence and highlighting the key conceptual and methodological gaps that must be addressed to clarify causality and to guide the development of preventive and therapeutic approaches targeting oral health in the context of AD.
- Open Access
- 31 August 2025
- Published by MDPI AG in Applied Sciences
- Vol. 15 (17) , 9590
The Role of Gut Microbiota in Food Allergies and the Potential Role of Probiotics for Their Treatment
The number of food allergies (FAs) is growing, particularly in industrialized countries, resulting in discomfort and a reduction in the quality of life of those who suffer from these allergies. Despite numerous epidemiological studies on FAs worldwide, the different approaches used constitute a limitation for an accurate prevalence of these disorders. The onset of FAs is multifactorial, since it depends on lifestyle, habitat, diet, and particularly on the diversity of gut microbiota. In fact, they occur in conditions of gut dysbiosis, an increase of the inflammatory state, an alteration of gut permeability, and an impairment of the resident immune cells, thus leading to a disruption and/or lack of tolerance towards food allergens. It is important to emphasize that the reduction of some bacteria leads to a decrease in their metabolite production, which, in turn, is crucial for the correct performance of immune responses and to ensure tolerance against allergens. Therefore, various strategies such as pre- and probiotic administration must be employed to avoid or prevent the onset of FAs.
- 31 August 2025
- Published by MDPI AG in Applied Sciences
- Vol. 15 (17) , 9590
Open AccessThe Role of Gut Microbiota in Food Allergies and the Potential Role of Probiotics for Their Treatment
The number of food allergies (FAs) is growing, particularly in industrialized countries, resulting in discomfort and a reduction in the quality of life of those who suffer from these allergies. Despite numerous epidemiological studies on FAs worldwide, the different approaches used constitute a limitation for an accurate prevalence of these disorders. The onset of FAs is multifactorial, since it depends on lifestyle, habitat, diet, and particularly on the diversity of gut microbiota. In fact, they occur in conditions of gut dysbiosis, an increase of the inflammatory state, an alteration of gut permeability, and an impairment of the resident immune cells, thus leading to a disruption and/or lack of tolerance towards food allergens. It is important to emphasize that the reduction of some bacteria leads to a decrease in their metabolite production, which, in turn, is crucial for the correct performance of immune responses and to ensure tolerance against allergens. Therefore, various strategies such as pre- and probiotic administration must be employed to avoid or prevent the onset of FAs.